BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16169865)

  • 1. The long-term effect of serum magnesium on cyclosporin A toxicity.
    Keven K; Canbakan B; Elhan AH
    Nephrol Dial Transplant; 2005 Dec; 20(12):2870. PubMed ID: 16169865
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporin A.
    Brünisholz MC; Bailey RR
    N Z Med J; 1985 Nov; 98(790):948-50. PubMed ID: 3909019
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum interleukin 2 activity in renal graft recipients.
    Sunder-Plassmann G; Stockenhuber F; Balcke P
    Transplant Proc; 1988 Jun; 20(3):387-9. PubMed ID: 3289167
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heart transplantation at the end of the 20th century].
    Alonso-Pulpón L
    Rev Clin Esp; 1999 Aug; 199(8):487-8. PubMed ID: 10522427
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term results of cyclosporine in cadaveric renal transplantation from a single center.
    Jain AB; Buckels JA; Adu D; Michael J; Mackintosh P; McMaster P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):82-5. PubMed ID: 3291320
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine and organ transplantation.
    Steinmuller DR
    Cleve Clin Q; 1985; 52(2):263-70. PubMed ID: 3161666
    [No Abstract]   [Full Text] [Related]  

  • 7. Does cyclosporin A affect neurotransmitters? Studies after kidney transplantation.
    Kopsa H; Lapin A; Derfler K; Stockenhuber F; Sunder-Plassmann G; Balcke P; Smetana R; Gebhart W
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1506-7. PubMed ID: 2565613
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possibilities of immunosuppressive therapy in reconstructive keratoplasty (experience gained in the use of cyclosporin)].
    Kasparov AA; Aladinskaia IV
    Vestn Oftalmol; 2002; 118(4):16-8. PubMed ID: 12371314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxicity of immunosuppressive agents.
    Vanrenterghem YF; Messiaen T
    Adv Nephrol Necker Hosp; 2001; 31():285-93. PubMed ID: 11692466
    [No Abstract]   [Full Text] [Related]  

  • 10. Normocalcaemic normomagnesaemic tetany with tacrolimus.
    Aiyangar A; Chowdhary P; Rao K; Kiran K
    Nephrology (Carlton); 2011 Nov; 16(8):784-5. PubMed ID: 22029645
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cyclosporin: key and border indications].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1989 Jan; 133(1):12-6. PubMed ID: 2644549
    [No Abstract]   [Full Text] [Related]  

  • 12. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
    Chapman JR; Nankivell BJ
    Nephrol Dial Transplant; 2006 Aug; 21(8):2060-3. PubMed ID: 16728428
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis.
    Furlanut M; Baraldo M; Galla F; Marzocchi V; Pea F
    Pharmacol Res; 1996 Jun; 33(6):349-52. PubMed ID: 8971957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kidney disorders induced by immunosuppressive agents].
    Morozumi K; Takeda A
    Nihon Naika Gakkai Zasshi; 1994 Oct; 83(10):1740-6. PubMed ID: 7529294
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients.
    Ahmadi F; Naseri R; Lessan-Pezeshki M
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):766-9. PubMed ID: 19736470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improving long-term graft survival by limiting nephrotoxicity of immunosuppressors and reducing vascular risk].
    Hourmant M
    Nephrol Ther; 2009 Dec; 5 Suppl 6():S353-4. PubMed ID: 20129444
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine. Problems in differential diagnosis--drug toxicity versus allograft rejection.
    Transplant Proc; 1983 Dec; 15(4 Suppl 1-2):2813-54. PubMed ID: 6364509
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary experience with cyclosporin A in human renal allografts.
    Fernando ON; Sweny P; Farrington K; Rogers H; Baillod RA; Chan MK; Varghese Z; Moorhead JF
    Transplant Proc; 1980 Jun; 12(2):244-5. PubMed ID: 6994292
    [No Abstract]   [Full Text] [Related]  

  • 20. An interim analysis of the on-going long-term safety study of cyclosporine in renal transplantation.
    Cockburn I; Götz E; Gülich A; Krupp P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):519-29. PubMed ID: 3291290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.